id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-N-3455-0005,FDA,FDA-2015-N-3455,Medical Devices: Exemption From Premarket Notification; Class II Devices; Autosomal Recessive Carrier Screening Gene Mutation Detection System,Rule,Final Rule,2017-11-07T05:00:00Z,2017,11,2017-11-07T05:00:00Z,,2017-11-07T15:25:39Z,2017-24162,0,0,0900006482c53e4a
FDA-2015-N-3455-0001,FDA,FDA-2015-N-3455,"Medical Devices; Exemptions From Premarket Notifications; Class II
Devices; Autosomal Recessive Carrier Screening Gene Mutation Detection System; Request for Comments",Notice,Notice of Intent,2015-10-27T04:00:00Z,2015,10,2015-10-27T04:00:00Z,2015-11-28T04:59:59Z,2015-11-28T22:00:33Z,2015-27198,0,0,0900006481cf1843